300
Participants
Start Date
January 1, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Adherence to the first prescribed antipsychotic medication
We shall compare adherence to the first prescribed antipsychotic medication and pragmatic clinical and functional outcomes between two cohorts of patients with first-episode psychosis. One cohort will be comprised of patients treated before the implementation of an early intervention in psychosis model of Personalised Precision Psychiatry including pharmacogenetics, and the other of patients treated under this new model. Also, we shall compare the pharmacogenetic profiles and possible phenocopies (variations of phenotypes produced environmentally, e.g., due to polypharmacy, rather than genetically) between these first episode psychosis patients and a national cohort of patients with longer-term psychotic disorders or with other mental health conditions, to evaluate potential implications for clinical management at different stages of a psychotic illness, and across mental disorders.
Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca
Carlos III Health Institute
OTHER_GOV
Instituto de Investigación Biomédica de Salamanca
OTHER